Third quarter reporting kicked off this month, once again showing the strong fundamentals of the sector. The sector outperformed world equities, with broad based performance. Tools name stood out with a recovery spurred by returning demand in end markets. At

September was a newsflow-heavy month, with multiple medical conferences and investor events.
Policy dynamics continue to dominate the sector despite broadly positive fundamentals news and clinical read-outs.